Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VAN DE WERF, Frans")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 118

  • Page / 5
Export

Selection :

  • and

New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?VAN DE WERF, Frans.European heart journal. 2009, Vol 30, Num 14, pp 1695-1702, issn 0195-668X, 8 p.Article

Dual antiplatelet therapy in high-risk patientsVAN DE WERF, Frans.European heart journal supplements. 2007, Vol 9D, issn 1520-765X, D3-D9Article

Regional challenges and opportunities in cardiovascular research: The Russian Federation SWOT analysisBOYTSOV, Sergey; VAN DE WERF, Frans.The American heart journal. 2011, Vol 161, Num 3, pp 427-430, issn 0002-8703, 4 p.Article

Year 2008 ESC ST-segment elevation myocardial infarction guidelines: implications for the interventional cardiologist―from evidence to recommendations and practiceVAN DE WERF, Frans.European heart journal supplements. 2009, Vol 11, Num C, issn 1520-765X, c31-c37Conference Paper

Reperfusion for ST-segment elevation myocardial infarction: An overview of current treatment optionsVAN DE WERF, Frans; BAIM, Donald S.Circulation (New York, N.Y.). 2002, Vol 105, Num 24, pp 2813-2816, issn 0009-7322Article

Left-to-right shunting in common congenital heart defects: which patients are eligible for percutaneous interventions?BUDTS, Werner; GEWILLIG, Marc; VAN DE WERF, Frans et al.Acta cardiologica. 2003, Vol 58, Num 3, pp 199-205, issn 0001-5385, 7 p.Article

Bolus fibrinolysis : Risk, benefit, and opportunitiesARMSTRONG, Paul W; GRANGER, Christopher; VAN DE WERF, Frans et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 8, pp 1171-1173, issn 0009-7322Article

Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait? The risk-time relationship and the need to quantify the impact of delayTARANTINI, Giuseppe; VAN DE WERF, Frans; BILATO, Claudio et al.The American heart journal. 2011, Vol 161, Num 2, pp 247-253, issn 0002-8703, 7 p.Article

Obesity management: The cardiovascular benefits. Proceedings of a meeting held in Cannes, April 2005JAMES, W. Philip T; VAN DE WERF, Frans.European heart journal supplements. 2005, Vol 7, Num L, issn 1520-765X, 54 p.Conference Proceedings

Failure of medicine : evolution of an atrial septal defect to an Eisenmenger syndromeBUDTS, Werner; VAN CLEEMPUT, Johan; VAN DE WERF, Frans et al.Acta cardiologica. 2000, Vol 55, Num 4, pp 265-267, issn 0001-5385Article

Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutterHEIDBÜCHEL, Hein; ANNE, Wim; WILLEMS, Rik et al.International journal of cardiology. 2006, Vol 107, Num 1, pp 67-72, issn 0167-5273, 6 p.Article

Meta-Analysis of Studies of Patients in the United Arab Emirates With ST-Elevation Myocardial Infarction Treated With Thrombolytic AgentsBINBREK, Azan S; RAO, Nayan S; VAN DE WERF, Frans et al.The American journal of cardiology. 2010, Vol 106, Num 12, pp 1692-1695, issn 0002-9149, 4 p.Article

Pharmacologic reperfusion therapy for acute myocardial infarctionLOWE, Harry C; MAC NEILL, Briain D; VAN DE WERF, Frans et al.Journal of thrombosis and thrombolysis. 2002, Vol 14, Num 3, pp 179-196, issn 0929-5305, 18 p.Article

Echocardiographic strain and strain-rate imaging: A new tool to study regional myocardial functionD'HOOGE, Jan; BIJNENS, Bart; JAN THOEN et al.IEEE transactions on medical imaging. 2002, Vol 21, Num 9, pp 1022-1030, issn 0278-0062, 9 p.Article

Comparison of errors in estimating weigh and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I)MURPHY, Sabina A; GIBSON, C. Michael; VAN DE WERF, Frans et al.The American journal of cardiology. 2002, Vol 90, Num 1, pp 51-54, issn 0002-9149Article

The Strategic Reperfusion Early After Myocardial Infarction (STREAM) studyARMSTRONG, Paul W; GERSHLICK, Anthony; GOLDSTEIN, Patrick et al.The American heart journal. 2010, Vol 160, Num 1, pp 30-35, issn 0002-8703, 6 p.Article

Intraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention: An Angiographic Substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy With Percutaneous Coronary Intervention) TrialZALEWSKI, Jaroslaw; BOGAERTS, Kris; DESMET, Walter et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 19, pp 1867-1873, issn 0735-1097, 7 p.Article

Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarctionGANAME, Javier; MESSALLI, Giancarlo; DYMARKOWSKI, Steven et al.European heart journal. 2009, Vol 30, Num 12, pp 1440-1449, issn 0195-668X, 10 p.Article

ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarctionARMSTRONG, Paul W; WAGNER, Galen; GOODMAN, Shaun G et al.European heart journal. 2003, Vol 24, Num 16, pp 1515-1522, issn 0195-668X, 8 p.Article

Circulating oxidized LDL is a useful marker for identifying patients with coronary artery diseaseHOLVOET, Paul; MERTENS, Ann; VERHAMME, Peter et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 5, pp 844-848, issn 1079-5642Article

Homograft survival after tetralogy of Fallot repair : determinants of accelerated homograft degenerationTROOST, Els; MEYNS, Bart; DAENEN, Willem et al.European heart journal. 2007, Vol 28, Num 20, pp 2503-2509, issn 0195-668X, 7 p.Article

What is the frequency and functional and clinical significance of complex lesions in non-infarct-related arteries after fibrinolysis for acute ST-elevation myocardial infarction?KIM, Daniel H; BURTON, Jeffrey R; YULING FU et al.The American heart journal. 2006, Vol 151, Num 3, pp 668-673, issn 0002-8703, 6 p.Article

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trialBJÖRKLUND, Erik; LINDAHL, Bertil; STENESTRAND, Ulf et al.The American heart journal. 2004, Vol 148, Num 4, pp 566-573, issn 0002-8703, 8 p.Article

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non―ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker TrendsTRICOCI, Pierluigi; LEONARDI, Sergio; HARRINGTON, Robert A et al.Journal of the American College of Cardiology. 2013, Vol 62, Num 3, pp 242-251, issn 0735-1097, 10 p.Article

Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic TherapyMEHTA, Rajendra H; STEBBINS, Amanda; ALEXANDER, John H et al.The American journal of medicine. 2011, Vol 124, Num 1, pp 48-57, issn 0002-9343, 10 p.Article

  • Page / 5